Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis

Wilkinson, Ian B.1,3; Fuchs, Sabine A.1; Jansen, Ilse M.1; Spratt, James C.1; Murray, Gordon D.1; Cockcroft, John R.2; Webb, David J.1

Original article

Objective The aim of this study was to determine the reproducibility of pulse wave velocity (PWV) and augmentation index (AIx) measured using pulse wave analysis (PWA), prior to its use in large-scale clinical trials.

Methods Arterial pressure waveforms were recorded and analysed using an established technique (Sphygmocor). Subjects with and without a range of recognized cardiovascular risk factors were studied to provide a wide range of values. Measurements were made after a brief introduction to the technique in a clinical setting. Two observers recorded aortic and brachial PWV in 24 subjects, each on two occasions, in a random order. In a separate study, two different observers used PWA to determine AIx in 33 subjects, each on two occasions, in a random order. Data were analysed using Bland-Altman plots and presented as mean ± SD.

Results Brachial PWV was 8.65 ± 1.58 m/s (range 6.16–10.95 m/s) and aortic PWV was 8.15 ± 3.01 m/s (5.01–17.97 m/s). Within-observer variability was 0.14 ± 0.82 m/s for brachial PWV and 0.07 ± 1.17 m/s for aortic PWV. Corresponding between-observer values were −0.44 ± 1.09 m/s and −0.30 ± 1.25 m/s. AIx ranged from −15.0 to + 45.0%, with a group mean of + 19.6 ± 12.0%. The within-observer difference was 0.49 ± 5.37% and between-observer difference 0.23 ± 3.80%.

Conclusion PWA is a simple and reproducible technique with which to measure PWV and AIx. Reproducibility accords with that reported by other workers using different methodologies. PWA may, therefore, be suitable for large-scale population and intervention studies investigating the clinical relevance of vascular stiffness.

1Clinical Pharmacology Unit, University of Edinburgh, Western General Hospital, Edinburgh, UK

2Department of Cardiology, University of Wales College of Medicine, University Hospital, Cardiff, UK

3Correspondence to Dr Ian B. Wilkinson, Clinical Pharmacology Unit, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK. Tel: + 44 131 537 1826; Fax: + 44 131 537 1009

Sponsorship: This study was made possible by a Biomedical Research Collaboration Grant from the Wellcome Trust.

© 1998 Lippincott Williams & Wilkins, Inc.